Highly c-oriented AEL aluminophosphate molecular sieve membranes were ionothermally synthesized on the surface of delta-alumina substrate by "Substrate Surface Conversion" method. The typical synthesis procedure can be described as follows: a delta-aluminia alumina disc was put into 1-ethyl-3-methyl imidazolium bromide ([EMIm]Br) solution containing reagent quantities of phosphoric acid (H3PO4) (85 wt% in water, AR) and hydrofluoric acid (HF) (40 wt% in water, AR). The synthesis was performed at 210 degrees C for certain time. No additional Al source is added into the synthesis solution. After the synthesis, the as-Synthesized sample was washed thoroughly with distilled water and acetone for several times by ultrasonic vibration and dried at 120 degrees C overnight. X-ray diffraction (XRD) and scanning electron microscopy (SEM) were carried out to characterize the products. The synthesis process of AEL membrane via "Substrate Surface Conversion" can be divided into two separated steps, which is carried out in the ionic liquid solution of HF and H3PO4 in turn. We termed this route as ionothermal two-step method, which making it possible for us to investigate the effect of BF and H3PO4, respectively. The formation mechanism of "Substrate Surface Conversion" was therefore demonstrated, with which the delta-alumina substrate acts as both support and Al source during the synthesis process. The surface of the substrate is first converted into a gel layer by the solution. The layer is a heterogeneous phase, which contains all nutrients required for the crystallization of molecular sieve membrane, including the aluminophosphate precursor, the mineralizer and the structure directing agent. The transformation from the gel layer into membrane is probably of solid-solid formation mechanism. The whole synthesis process needs the participation of both H3PO4 and HF. H3PO4 is an essential component of both aluminophosphate precursor and molecular sieve crystal. The crystallinity and the orientation of synthesized membranes can be greatly influenced by adjusting the amount of BF in the initial solution, which may act as both structure directing agent and mineralizer during the synthesis process of molecular sieve membrane.
机构:
China Med Univ, Coll Pharm, Dept Clin Pharmacol, Shenyang 110001, Peoples R China
Zhongshan City Peoples Hosp, Dept Pharm, Zhongshan 528403, Peoples R ChinaChina Med Univ, Coll Pharm, Dept Clin Pharmacol, Shenyang 110001, Peoples R China
Li, Xue-qin
Wang, Han-ming
论文数: 0引用数: 0
h-index: 0
机构:
China Med Univ, Coll Pharm, Dept Clin Pharmacol, Shenyang 110001, Peoples R ChinaChina Med Univ, Coll Pharm, Dept Clin Pharmacol, Shenyang 110001, Peoples R China
Wang, Han-ming
Yang, Chun-guang
论文数: 0引用数: 0
h-index: 0
机构:
China Med Univ, Coll Pharm, Dept Clin Pharmacol, Shenyang 110001, Peoples R ChinaChina Med Univ, Coll Pharm, Dept Clin Pharmacol, Shenyang 110001, Peoples R China
Yang, Chun-guang
Zhang, Xin-hua
论文数: 0引用数: 0
h-index: 0
机构:
China Med Univ, Coll Pharm, Dept Clin Pharmacol, Shenyang 110001, Peoples R ChinaChina Med Univ, Coll Pharm, Dept Clin Pharmacol, Shenyang 110001, Peoples R China
Zhang, Xin-hua
Han, Dan-dan
论文数: 0引用数: 0
h-index: 0
机构:
China Med Univ, Coll Pharm, Dept Clin Pharmacol, Shenyang 110001, Peoples R ChinaChina Med Univ, Coll Pharm, Dept Clin Pharmacol, Shenyang 110001, Peoples R China
Han, Dan-dan
Wang, Huai-liang
论文数: 0引用数: 0
h-index: 0
机构:
China Med Univ, Coll Pharm, Dept Clin Pharmacol, Shenyang 110001, Peoples R China
China Med Univ, Div Resp Dis, Shenyang 110001, Peoples R ChinaChina Med Univ, Coll Pharm, Dept Clin Pharmacol, Shenyang 110001, Peoples R China
机构:
China Med Univ, Coll Pharm, Dept Clin Pharmacol, Shenyang 110001, Peoples R China
Zhongshan City Peoples Hosp, Dept Pharm, Zhongshan 528403, Peoples R ChinaChina Med Univ, Coll Pharm, Dept Clin Pharmacol, Shenyang 110001, Peoples R China
Li, Xue-qin
Wang, Han-ming
论文数: 0引用数: 0
h-index: 0
机构:
China Med Univ, Coll Pharm, Dept Clin Pharmacol, Shenyang 110001, Peoples R ChinaChina Med Univ, Coll Pharm, Dept Clin Pharmacol, Shenyang 110001, Peoples R China
Wang, Han-ming
Yang, Chun-guang
论文数: 0引用数: 0
h-index: 0
机构:
China Med Univ, Coll Pharm, Dept Clin Pharmacol, Shenyang 110001, Peoples R ChinaChina Med Univ, Coll Pharm, Dept Clin Pharmacol, Shenyang 110001, Peoples R China
Yang, Chun-guang
Zhang, Xin-hua
论文数: 0引用数: 0
h-index: 0
机构:
China Med Univ, Coll Pharm, Dept Clin Pharmacol, Shenyang 110001, Peoples R ChinaChina Med Univ, Coll Pharm, Dept Clin Pharmacol, Shenyang 110001, Peoples R China
Zhang, Xin-hua
Han, Dan-dan
论文数: 0引用数: 0
h-index: 0
机构:
China Med Univ, Coll Pharm, Dept Clin Pharmacol, Shenyang 110001, Peoples R ChinaChina Med Univ, Coll Pharm, Dept Clin Pharmacol, Shenyang 110001, Peoples R China
Han, Dan-dan
Wang, Huai-liang
论文数: 0引用数: 0
h-index: 0
机构:
China Med Univ, Coll Pharm, Dept Clin Pharmacol, Shenyang 110001, Peoples R China
China Med Univ, Div Resp Dis, Shenyang 110001, Peoples R ChinaChina Med Univ, Coll Pharm, Dept Clin Pharmacol, Shenyang 110001, Peoples R China